Diabetes drug slows kidney function decline
Clinical trial data reveal that dapagliflozin— a sodium-glucose cotransporter 2 inhibitor prescribed to treat diabetes—reduces the rate of kidney function decline in patients with chronic kidney disease (CKD). The findings ...
Nov 6, 2021
0
60